Evidence map›Paper›PMID 38236720›Full record

ArticleBrain : a journal of neurology2024

Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.

Mukesh Kumar, Noé Quittot, Simon Dujardin, Christoph N Schlaffner, Arthur Viode, Anne Wiedmer, Pieter Beerepoot, Joshua E Chun, Calina Glynn, Analiese R Fernandes and 3 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Tau biology, biomarkers, and therapeutics.Alzheimer's & dementia (New York, N. Y.)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mukesh KumarDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Noé QuittotDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Simon DujardinDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-5614-341X
Christoph N SchlaffnerDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Arthur ViodeDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Anne WiedmerAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.
Pieter BeerepootDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Joshua E ChunDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Calina GlynnDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Analiese R FernandesAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0002-3906-7806
Cameron DonahueAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.
Judith A SteenDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8167-0772
Bradley T HymanDepartment of Neurology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-7959-9401

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI STEVEN E ARNOLD · 2019 to 2026
$36.5M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Patient-Based Structural Biology of Tauopathies and TDP-43 Proteinopathies using Cryo-Electron Microscopy and Mass SpectrometryU01NS110438 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FITZPATRICK, ANTHONY WILLIAM PAUL, PETRUCELLI, LEONARD · 2018 to 2022
$7.8M
Integrated Platform to study Neurodegeneration in Alzheimer’s DiseaseR01AG071858 · NIA · BOSTON CHILDREN'S HOSPITAL · PI STEEN, JUDITH A · 2021 to 2025
$3.9M
Are multiple tau species toxic in Alzheimer's Disease?RF1AG059789 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 2018 to 2018
$2.7M
Synergy between amyloid and tau in Alzheimer's DiseaseRF1AG058674 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 2018 to 2018
$2.6M
Complexity and Heterogeneity of Alzheimer diseaseR56AG061196 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 2019 to 2019
$654k
Alzheimer's Association 2018-AARF-591935NIA NIH HHS P30 AG062421NIA NIH HHS R01 AG071858NIA NIH HHS R56 AG061196NIA NIH HHS RF1 AG058674NIA NIH HHS RF1 AG059789NICHD NIH HHS P50 HD105351NIH HHS R56AG061196NINDS NIH HHS U01 NS110438
6 · The paper itself

Abstract

Aggregation prone molecules, such as tau, form both historically well characterized fibrillar deposits (neurofibrillary tangles) and recently identified phosphate-buffered saline (PBS) extract species called proteopathic seeds. Both can cause normal endogenous tau to undergo templated misfolding. The relationship of these seeds to the fibrils that define tau-related diseases is unknown. We characterized the aqueous extractable and sarkosyl insoluble fibrillar tau species derived from human Alzheimer brain using mass spectrometry and in vitro bioassays. Post-translational modifications (PTMs) including phosphorylation, acetylation and ubiquitination are identified in both preparations. PBS extract seed competent tau can be distinguished from sarkosyl insoluble tau by the presence of overlapping, but less abundant, PTMs and an absence of some PTMs unique to the latter. The presence of ubiquitin and other PTMs on the PBS-extracted tau species correlates with the amount of tau in the seed competent size exclusion fractions, with the bioactivity and with the aggressiveness of clinical disease. These results demonstrate that the PTMs present on bioactive, seed competent PBS extract tau species are closely related to, but distinct from, the PTMs of mature paired helical filaments, consistent with the idea that they are a forme fruste of tau species that ultimately form fibrils.

Indexed as

Alzheimer DiseaseNeurofibrillary TanglesHumansPhosphorylationProtein Processing, Post-Translationaltau Proteinstau Proteinshuman Alzheimer diseasemass spectrometryneurodegenerationproteomicsPTMTau protein

Identifiers

PMID38236720
PMCPMC10834235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.